SS Innovations International, Inc. SSII
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-07-09
SS Innovations International, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 46.0% | 40.9% | 12.3% | — | — |
| Operating margin | -19.3% | -91.9% | -345.1% | — | — |
| Net margin | -28.5% | -92.7% | -355.4% | — | — |
| FCF margin | -52.3% | -49.2% | -269.2% | — | — |
| Return on assets | -16.3% | -45.2% | -66.2% | -64.6% | -346.3% |
| Return on equity | -31.7% | -142.3% | -105.9% | 209.1% | 892.1% |
| Current ratio | 1.86 | 1.29 | 2.53 | 0.60 | 1.42 |
| Revenue growth | 105.7% | 251.5% | — | — | — |
Source: SEC EDGAR filings · CIK 0001676163 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.